Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Dec 21
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Experts predict growth in Pharma-AI use research

Nov 3
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Cambridge-1 and the future of medicine

Dec 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Analysts forecast LS tech and business trend of 2022

Oct 18
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gartner survey of CIOs highlights investments in AI, cloud and cybersecurity

Sep 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Arabesque launches the world’s first AI-powered ESG portfolio manager

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

What’s big in A.I. this year

Sep 21
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Artificial intelligence a key challenge for Germany's next government

Mar 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Do Algorithms Make Better and Fairer Investments Than Angel Investors?

Dec 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI drug discovery platform raises Series B funding

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie